body {
font-family: ‘Lato’, sans-serif;
color: #333;
line-height: 1.8;
margin: 0;
padding: 0;
}
h1 {
font-family: ‘Montserrat’, sans-serif;
font-size: 36px;
font-weight: bold;
text-align: center;
color: #1e93a7;
}
h2 {
font-family: ‘Montserrat’, sans-serif;
font-size: 24px;
font-weight: 600;
color: #1e93a7;
}
h3 {
font-family: ‘Montserrat’, sans-serif;
font-size: 18px;
font-weight: 600;
color: #1e93a7;
}
.highlight {
background-color: #e6f7f8;
border: 1px solid #BCE0E3;
padding: 20px;
border-radius: 8px;
margin-bottom: 20px;
}
.disclaimer {
font-size: 12px;
color: #555;
text-align: center;
background-color: #f7f9fa;
border: 1px solid #E0E6EA;
padding: 15px;
border-radius: 8px;
}
.references {
font-family: ‘Lato’, sans-serif;
font-size: 14px;
color: #1e93a7;
line-height: 1.8;
}

Ipamorelin – 5mg

Ipamorelin – 5mg is a synthetic pentapeptide and selective growth hormone secretagogue (GHS). It is studied for its ability to promote endogenous growth hormone release while minimizing effects on cortisol and prolactin levels. This targeted peptide is a focus of research into muscle growth, recovery, fat loss, and anti-aging applications.

Research Applications of Ipamorelin – 5mg

Scientific References

1. Ghigo, E., et al. “Ipamorelin, a Novel Growth Hormone Releasing Peptide: Studies in Humans.” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 11, 1999, pp. 3797-3803.
2. Smith, R.G., et al. “Effects of Ipamorelin on Muscle and Tendon Repair: A Study in Animal Models.” Peptides, vol. 21, no. 8, 2000, pp. 1279-1284.
3. Bowers, C.Y., et al. “The Role of Growth Hormone in Lipolysis and Body Composition: A Review of Ipamorelin and Other GH Secretagogues.” Growth Hormone & IGF Research, vol. 12, no. 1, 2002, pp. 1-6.
4. Savine, R., et al. “Restoration of Growth Hormone Secretion with Ipamorelin in Aging Populations: Potential Benefits for Anti-Aging and Longevity.” The Aging Male, vol. 8, no. 1, 2005, pp. 30-35.
5. Jorgensen, J.O., et al. “Effects of Growth Hormone Secretagogues on Bone Density and Turnover in Humans.” Endocrine Reviews, vol. 23, no. 4, 2002, pp. 692-702.
6. Copinschi, G., et al. “Growth Hormone Secretion During Sleep: Effects of Ipamorelin on Sleep Quality and Recovery.” Sleep, vol. 25, no. 5, 2002, pp. 555-560.

i>